Income, investors, rely, dividends, favorite, stocks, pay, The, worst, news, investors, get, company, cut, dividend, That, might, seem, like, something, would, happen, often, investors, blue, chip, conglomerate, General, Electric, latest, learn, even, largest, companies, face, financial, challenges, threaten, ability, pay, dividends, 
Recently, Coca, Cola, Merck, Chevron, faced, challenges, sent, dividend, payout, ratios, 100, mark, That, usually, sign, danger, dividend, stocks, three, cases, good, reasons, investors, panic, Below, look, closely, three, companies, show, safer, look, first, glance, 
Stock, 
Dividend, Yield, 
Payout, Ratio, 
Coca, Cola, NYSE, KO, 
3, 2, 
140, 
Merck, NYSE, MRK, 
3, 4, 
181, 
Chevron, NYSE, CVX, 
3, 4, 
126, 
DATA, SOURCE, YAHOO, FINANCE, 
Coca, Cola, tough, 2017, underperforming, broader, market, faced, prospect, make, major, modifications, business, Attacks, company, namesake, sugary, beverages, led, sluggish, growth, segment, Coca, Cola, business, taken, dramatic, shifts, toward, product, lines, like, bottled, water, still, beverages, company, hold, amid, weakness, carbonated, beverage, lineup, Reported, earnings, fallen, roughly, third, past, 12, months, sending, Coca, Cola, payout, ratio, soaring, 
IMAGE, SOURCE, COCA, COLA, 
Much, negative, impact, Coca, Cola, bottom, line, come, one, time, charges, related, restructuring, asset, sales, The, company, sought, refranchise, bottling, operations, separate, companies, look, losses, sales, assets, asset, writedowns, restructuring, charges, Coca, Cola, taken, hit, 3, 2, billion, With, restructuring, complete, investors, expect, earnings, climb, back, toward, 2, per, share, level, would, bring, payout, ratio, back, reasonable, 75, 
Merck, ran, substantial, problems, late, year, combination, poor, financial, results, questionable, strategic, moves, leading, crisis, confidence, among, investors, The, drug, giant, third, quarter, report, showed, weakness, sales, raised, concerns, earnings, growth, decision, withdraw, application, European, regulators, approve, Keytruda, cancer, treatment, first, line, use, resulted, shareholders, worrying, key, drug, future, 
With, Merck, investors, look, closely, financial, moves, company, makes, write, value, assets, In, late, 2016, recorded, 3, 6, billion, impairment, charges, related, process, research, development, assets, related, HCV, treatment, uprifosbuvir, Such, charges, uncommon, previous, years, corresponding, R, D, related, charges, less, 65, million, As, long, similar, charges, recur, Merck, earnings, poised, recover, 3, per, share, 2018, would, put, payout, ratio, around, 65, 
Chevron, epicenter, oil, market, turbulence, recent, years, falling, crude, prices, weighing, deeply, integrated, oil, giant, earnings, power, Weaker, production, weighed, earnings, generous, dividend, policy, past, prices, justified, looks, somewhat, overextended, 
Lately, energy, market, cooperated, Chevron, likely, put, oil, giant, better, position, going, forward, In, addition, completion, liquefied, natural, gas, projects, Australia, help, reduce, capital, spending, produce, new, sources, income, Those, looking, stock, expect, 5, 25, per, share, earnings, 2018, would, send, Chevron, payout, ratio, 80, That, low, would, prefer, see, big, improvement, past, several, years, 
Looking, payout, ratios, context, lead, major, concerns, dividend, investors, By, looking, facts, behind, numbers, often, reach, greater, comfort, level, challenges, facing, companies, get, confidence, ability, sustain, dividend, payments, futures, 
Before, consider, Merck, Co, Inc, want, hear, 
Investing, legends, Motley, Fool, Co, founders, David, Tom, Gardner, revealed, believe, 10, best, stocks, investors, buy, right, Merck, Co, Inc, one, 
Stock, Advisor, returns, May, 11, 2021, 
